Can Optical Computing Bounce Back?

Spend money on optical computers? That would be like spending it on fusion-powered desk lamps. Even if the technology problems could be solved--which they can't--the final product won't do the job any better than what we've already got. For two decades this has been the prevailing attitude of research strategists at industrial corporations toward optical computing. But all that may begin to change next week at an Optical Society of America meeting in Salt Lake City. For almost 20 years, comput

Written byRobert Crease
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

For two decades this has been the prevailing attitude of research strategists at industrial corporations toward optical computing. But all that may begin to change next week at an Optical Society of America meeting in Salt Lake City. For almost 20 years, computer scientists pursuing the dream that computers could run on light rather than electric pulses have been on the defensive, charged by some physicists with willfully overlooking what's competitive, what's practical, and even what's scientifically feasible. At the OSA meeting, however, a physicist will try to come to the rescue of the computer scientists; AT&T Bell Laboratories physicist David A.B. Miller, head of Bell's Photonics Switching Device Research Department, will present a paper naming a crucial aspect of the internal workings of computers where, in principle, optics beats electronics.

While unlikely to change minds overnight, the added clout of a physicist's paper just might attract the attention of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies